Practical Nursing Strategies to Optimize the Care of Patients With NSCLC Receiving Immunotherapy

In this series of CE-certified live meetings, expert faculty provide perspective on optimizing nursing care for patients with NSCLC receiving immunotherapy.


  • Program Overview
  • Principles of Immunotherapies: An Overview
  • Current and Investigational Immunotherapies for NSCLC and Their Implications on Current Therapy Decisions
  • Case-Based Application of Nursing Considerations and Adverse Event Management
  • Closing Remarks and Audience Question and Answer Session


Date / Time
Event Details


Maura Abbott, PhD, AOCNP, CPNP

Assistant Professor of Nursing
Oncology Program Director
Nurse Practitioner
Department of Hematology/Oncology
Columbia University Medical Center
New York, New York

Beth Eaby-Sandy, MSN, CRNP, OCN

Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania

Diane Cope, PhD, ARNP-BC, AOCNP

Director of Nursing
Oncology Nurse Practitioner
Florida Cancer Specialists and Research Institute
Fort Myers, Florida

Gail Kwarciany, MSN, RN-BC, OCN, AOCNS

Oncology Clinical Nurse Specialist
The University of Texas Medical Branch
Galveston, Texas

Kristi Kay Orbaugh, RN, MSN, RNP, AOCN

Adult Oncology Nurse Practitioner
Community Hospital Oncology Physicians
Indianapolis, Indiana

Michelle Turner, MS, CRNP

Nurse Practitioner Manager
Kimmel Cancer Center
Johns Hopkins Hospital
Baltimore, Maryland

Program Overview
This series of hour-long, interactive, case-based workshops examines the role of the nurse in caring for patients with NSCLC who are receiving immunotherapy. Expert oncology nurses will highlight the latest available immune checkpoint inhibitors for NSCLC as well as strategies for adverse event management and optimal communication that positions patients to optimally benefit from immunotherapy.

Goal Statement
The goal of this activity is to improve participants’ competence in helping patients with non-small-cell lung cancer understand and maximally benefit from immunotherapy.

Target Audience
This program is intended for registered nurses and other healthcare providers who provide care for patients with non-small-cell lung cancer.

Learning Objectives

  • Describe to patients the key principles underlying immunotherapy
  • Evaluate the clinical data to be able to discuss the efficacy and safety of current and emerging immune checkpoint inhibitors for NSCLC
  • Develop management strategies for immunotherapy-associated adverse events


Nursing Continuing Education

Credit Designation

This educational activity for 1.0 contact hour is provided by Postgraduate Institute for Medicine.

Accreditation Statement
Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 1.0 contact hour.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within 3 weeks.

Disclosure of Conflicts of Interest 
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.